MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.7100
-0.0096 (-1.33%)
Feb 17, 2026, 9:30 AM EST - Market open
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $75.74 million as of February 17, 2026. Its market cap has decreased by -84.39% in one year.
Market Cap
75.74M
Enterprise Value
-10.80M
1-Year Change
-84.39%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $75.74M, a decrease of -84.69%. That is a compound annual growth rate of -31.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 76.76M | -53.57% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Picard Medical | 114.97M |
| Hyperfine | 107.86M |
| Sera Prognostics | 104.40M |
| Neuronetics | 97.25M |
| Xtant Medical Holdings | 81.83M |
| InspireMD | 74.15M |
| QT Imaging Holdings | 66.84M |
| Sensus Healthcare | 63.55M |